| Patents for C07K 19 - Hybrid peptides (29,428) | 
|---|
| 09/08/1995 | WO1995023512A1 Terminal complement inhibitor fusion genes and proteins | 
| 09/08/1995 | CA2184810A1 Product and process for t cell regulation | 
| 09/08/1995 | CA2184356A1 Terminal complement inhibitor fusion genes and proteins | 
| 09/08/1995 | CA2184355A1 Chimeric complement inhibitor proteins | 
| 09/06/1995 | EP0670332A2 Protein complexes having factor VIII:C activity and production thereof | 
| 09/06/1995 | EP0669982A1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins | 
| 09/06/1995 | EP0669979A1 C-c ckr-1, c-c chemokine receptor | 
| 09/06/1995 | EP0669933A1 PURIFICATION OF FUSION PROTEINS COMPRISING GM-CSF and IL-3 | 
| 09/06/1995 | EP0669929A1 Novel cytokine designated elk ligand | 
| 09/06/1995 | EP0529075B1 Hybrid calcitonin | 
| 09/06/1995 | EP0151579B1 Method and products for detection of human t cell leukemia virus | 
| 09/05/1995 | US5447913 Therapeutic uses of bactericidal/permeability-increasing protein dimer products | 
| 09/05/1995 | US5447852 DNA encoding cyclophilin C, and recombinant methods employing it | 
| 09/05/1995 | US5447851 DNA encoding a chimeric polypeptide comprising the extracellular domain of TNF receptor fused to IgG, vectors, and host cells | 
| 08/31/1995 | WO1995023163A1 Pna combinatorial libraries and improved methods of synthesis | 
| 08/31/1995 | WO1995022987A1 Urease-based vaccine and treatment for helicobacter infection | 
| 08/31/1995 | WO1995022980A1 Inhibin compositions and methods of use thereof | 
| 08/31/1995 | WO1995022977A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same | 
| 08/31/1995 | WO1995016036A3 IFN-ηRECEPTOR β-CHAIN AND DERIVATIVES THEREOF | 
| 08/31/1995 | CA2184057A1 Urease-based vaccine and treatment for helicobacter infection | 
| 08/31/1995 | CA2183535A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same | 
| 08/30/1995 | EP0669394A1 Bifunctional derivatives of Urokinase with improved fibrinolytic activity and Thrombin inhibiting activity | 
| 08/30/1995 | EP0668924A1 HUMANIZED ANTIBODIES TO Fc RECEPTORS FOR IMMUNOGLOBULIN G ON HUMAN MONONUCLEAR PHAGOCYTES | 
| 08/30/1995 | EP0668909A1 Transgenic, cross-linked hemoglobin | 
| 08/30/1995 | EP0668875A1 Clot directed anticoagulant, process for making same and methods of use | 
| 08/30/1995 | EP0668777A1 Prostate-specific membrane antigen | 
| 08/29/1995 | US5445940 Methods and compositions for detecting and treating a subset of human patients having an autoimmune disease | 
| 08/29/1995 | CA1336826C Chimeric antibody with specificity to human b cell surface antigen | 
| 08/24/1995 | WO1995022618A1 Nucleic acid delivery system, method of synthesis and uses thereof | 
| 08/24/1995 | WO1995022340A1 Methods for altering fertility | 
| 08/24/1995 | CA2183667A1 Nucleic acid delivery system, method of synthesis and uses thereof | 
| 08/23/1995 | EP0668077A1 Compositions containing G-CSF and TNF binding protein | 
| 08/23/1995 | EP0500576B1 Outer membrane protein p1 and peptides of haemophilus influenzae type b | 
| 08/22/1995 | US5444158 Merosin, nucleic acids encoding, fragments and uses thereof | 
| 08/22/1995 | US5444153 Plasminogen activator inhibitor which has been altered to eliminate a protease sensitive site | 
| 08/22/1995 | US5443955 Receptor membranes and ionophore gating | 
| 08/22/1995 | US5443828 AIDS vaccine | 
| 08/22/1995 | US5443827 Chimeric molecule; anticoagulants | 
| 08/17/1995 | WO1995021915A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells | 
| 08/17/1995 | WO1995021528A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells | 
| 08/17/1995 | CA2183066A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells | 
| 08/16/1995 | EP0666914A1 Novel p-selectin ligand protein | 
| 08/16/1995 | EP0605410B1 Immunodiagnostic assay for rheumatoid arthritis | 
| 08/16/1995 | EP0532525B1 New protein-polycation conjugates | 
| 08/16/1995 | EP0439462B1 Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection | 
| 08/16/1995 | EP0371999B1 Nucleic acid and methods for the synthesis of novel fusion polypeptides with a phospholipid anchor domain | 
| 08/15/1995 | CA1336691C Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects | 
| 08/10/1995 | WO1995021267A1 Heat-inducible n-degron module | 
| 08/10/1995 | WO1995021258A1 Fusion proteins that include antibody and nonantibody portions | 
| 08/10/1995 | WO1995021254A1 Multivariant il-3 hematopoiesis fusion protein | 
| 08/10/1995 | WO1995021197A1 Il-3 variant hematopoiesis fusion protein | 
| 08/10/1995 | CA2182498A1 Fusion proteins that include antibody and nonantibody portions | 
| 08/10/1995 | CA2182484A1 Multivariant il-3 hematopoiesis fusion protein | 
| 08/09/1995 | EP0666270A2 Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoprotein | 
| 08/09/1995 | EP0665955A1 Particles having gelatin-aminodextran coatings of and processes for making same | 
| 08/09/1995 | EP0535007B1 A MONOCLONAL ANTIBODY AGAINST THE GAG PROTEIN PRECURSOR p55 OF HUMAN IMMUNODEFICIENCY VIRUS | 
| 08/09/1995 | EP0490972B1 Recombinant negative strand rna virus expression systems and vaccines | 
| 08/09/1995 | CA2140379A1 Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus e7 oncoprotein | 
| 08/08/1995 | US5439829 Bonding chelating agent to biologically active molecule on a support, treating with oxidizing or reducing agent to change oxidation state of chelating metal ion and immobilize active molecule on the support | 
| 08/08/1995 | US5439820 Anti-thrombin polypeptides | 
| 08/08/1995 | US5439807 Methods for the preparation of endotoxin-binding proteins | 
| 08/03/1995 | WO1995020665A1 Expression of heterologous proteins in attenuated bacteria using the htra-promoters | 
| 08/03/1995 | WO1995020664A2 Mammalian expression systems for hepatitis c virus envelope genes | 
| 08/03/1995 | CA2182170A1 Mammalian expression systems for hepatitis c virus envelope genes | 
| 08/02/1995 | EP0665289A2 Peptides from GAD65, provoking autoimmune reactions | 
| 08/02/1995 | EP0631586A4 Amino procollagen 1(i) peptides. | 
| 08/01/1995 | CA1336497C Immunoconjugates for cancer diagnosis and therapy | 
| 07/26/1995 | EP0664336A1 Saccharomyces specific antigenes and antibodies, their preparation and their use | 
| 07/26/1995 | EP0663925A1 Affinity purification methods involving amino acid mimetics as elution reagents | 
| 07/26/1995 | CA2140988A1 Saccharomyces-specific antigens and antibodies, their preparation and use | 
| 07/25/1995 | US5436321 Antibodies to the lipopolysaccharide bonding opsonin septin | 
| 07/25/1995 | US5436170 Crosslinking | 
| 07/25/1995 | US5436157 Human intra-acrosomal sperm antigen | 
| 07/21/1995 | CA2140591A1 Antigen-specific, activated t lymphocytes, detection and use | 
| 07/20/1995 | WO1995019371A2 Expression of surface layer proteins | 
| 07/20/1995 | DE19500723A1 New variable domains of antibody recognising cancer specific mucin | 
| 07/19/1995 | EP0332677B1 Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same | 
| 07/19/1995 | EP0198015B2 Production of streptavidin-like polypeptides | 
| 07/18/1995 | US5434287 Bifunctional DTPA-type ligand | 
| 07/18/1995 | US5434245 Osteocalcin | 
| 07/18/1995 | US5434131 Chimeric CTLA4 receptor and methods for its use | 
| 07/18/1995 | US5434077 Borrelia burgdorferi strain 257 | 
| 07/18/1995 | US5434073 Fibrinolytic and anti-thrombotic cleavable dimers | 
| 07/18/1995 | CA1336329C Fusion proteins, a process for their preparation and their use | 
| 07/13/1995 | WO1995018858A1 Thrombopoietin | 
| 07/12/1995 | EP0662482A1 Process for preparation of human glicentin | 
| 07/12/1995 | EP0662150A1 Maspin, a novel serpin with tumor suppressing activity | 
| 07/12/1995 | EP0662093A1 Hiv immunotherapeutics | 
| 07/12/1995 | EP0662086A1 Protein l and hybrid proteins thereof | 
| 07/12/1995 | CN1105030A Erythropoietin analogs | 
| 07/06/1995 | WO1995018381A1 Immunoassays for prostate specific antigen | 
| 06/29/1995 | WO1995017427A1 Acylated protein aggregates and their use in enhancing signals in an immunoassay testing for antibodies | 
| 06/29/1995 | WO1995017412A1 NOVEL HUMAN β2 INTEGRIN ALPHA SUBUNIT | 
| 06/29/1995 | WO1995017202A1 Method of preventing or treating disease characterized by neoplastic cells expressing cd40 | 
| 06/29/1995 | CA2179196A1 Method of preventing or treating disease characterized by neoplastic cells expressing cd40 | 
| 06/29/1995 | CA2156622A1 Novel human .beta.2 integrin alpha subunit | 
| 06/29/1995 | CA2139155A1 Process for preparation of human glicentin | 
| 06/28/1995 | EP0659439A2 Immunoconjugates | 
| 06/28/1995 | EP0659217A1 CLONING AND EXPRESSION OF $g(b)APP-C100 RECEPTOR | 
| 06/28/1995 | EP0625157A4 PLATELET GPIIIa P1?A1 AND P1?A2 EPITOPES, THEIR PREPARATION AND USE. |